###begin article-title 0
Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">H-2q</span>
Arthritis induced by immunisation with glucose-6-phosphate isomerase (GPI) in DBA/1 mice was proven to be T helper (Th) 17 dependent. We undertook this study to identify GPI-specific T cell epitopes in DBA/1 mice (H-2q) and investigate the mechanisms of arthritis generation.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 265 270 <span type="species:ncbi:9606">Human</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 795 800 <span type="species:ncbi:10090">mouse</span>
For epitope mapping, the binding motif of the major histocompatibility complex (MHC) class II (I-Aq) from DBA/1 mice was identified from the amino acid sequence of T cell epitopes and candidate peptides of T cell epitopes in GPI-induced arthritis were synthesised. Human GPI-primed CD4+ T cells and antigen-presenting cells (APCs) were co-cultured with each synthetic peptide and the cytokine production was measured by ELISA to identify the major epitopes. Synthetic peptides were immunised in DBA/1 mice to investigate whether arthritis could be induced by peptides. After immunisation with the major epitope, anti-interleukin (IL) 17 monoclonal antibody (mAb) was injected to monitor arthritis score. To investigate the mechanisms of arthritis induced by a major epitope, cross-reactivity to mouse GPI peptide was analysed by flow cytometry and anti-GPI antibodies were measured by ELISA. Deposition of anti-GPI antibodies on the cartilage surface was detected by immunohistology.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 610 615 <span type="species:ncbi:10090">mouse</span>
###xml 660 665 <span type="species:ncbi:10090">mouse</span>
We selected 32 types of peptides as core sequences from the human GPI 558 amino acid sequence, which binds the binding motif, and synthesised 25 kinds of 20-mer peptides for screening, each containing the core sequence at its centre. By epitope mapping, human GPI325-339 was found to induce interferon (IFN) gamma and IL-17 production most prominently. Immunisation with human GPI325-339 could induce polyarthritis similar to arthritis induced by human GPI protein, and administration of anti-IL-17 mAb significantly ameliorated arthritis (p < 0.01). Th17 cells primed with human GPI325-339 cross-reacted with mouse GPI325-339, and led B cells to produce anti-mouse GPI antibodies, which were deposited on cartilage surface.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human GPI325-339 was identified as a major epitope in GPI-induced arthritis, and proved to have the potential to induce polyarthritis. Understanding the pathological mechanism of arthritis induced by an immune reaction to a single short peptide could help elucidate the pathogenic mechanisms of autoimmune arthritis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1040 1041 1040 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 400 406 <span type="species:ncbi:10090">murine</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
Rheumatoid arthritis (RA) is characterised by symmetrical polyarthritis and joint destruction. Although the aetiology is considered to be autoimmune reactivity to some antigens, the exact mechanisms are not fully understood. So far, several models of arthritis have been described and analysed to understand the aetiological mechanisms of RA. Glucose-6-phosphate isomerase (GPI)-induced arthritis, a murine model of RA, is induced by immunisation with recombinant human (rh) GPI of DBA/1 mice [1]. We have previously demonstrated that the T helper (Th) 17 subset of CD4+ T cells play a central role in the pathogenesis of GPI-induced arthritis; GPI-specific CD4+ T cells were skewed to Th17 at the time of onset, and blockade of interleukin (IL) 17 resulted in a significant amelioration of arthritis [2]. Furthermore, the data that the administration of cytotoxic T-lymphocyte antigen 4 immunoglobulin (CTLA-4 Ig) in the effector phase ameliorated the progress of arthritis implies the importance of Th17 cells even in the effector phase [3].
###end p 11
###begin p 12
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 108 116 108 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 182 190 182 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 261 268 261 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270</sub>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 625 632 625 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 680 688 680 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 232 238 <span type="species:ncbi:9913">bovine</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 664 669 <span type="species:ncbi:10090">mouse</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
In this study, we further explored the epitopes of GPI-specific CD4+ T cells and identified human GPI (hGPI)325-339 as a major epitope. Interestingly, the amino acid sequence of hGPI325-339 (IWYINCFGCETHAML) was the same as that of bovine (type II collagen) CII256-270(GEPGIAGFKGEQGPK), the dominant epitope of collagen-induced arthritis (CIA), at the major histocompatibility complex (MHC) binding sites [4]. Of note is that arthritis similar to GPI-induced arthritis was generated by immunisation with a short 15-mer single peptide in genetically unaltered mice. By analysis of peptide-induced arthritis, we found that hGPI325-339-primed Th17 cells reacted with mouse GPI (mGPI)325-339 peptide and subsequently lead to the production of anti-mouse GPI antibodies, which deposited over the cartilage surface of inflaming joints. Our findings should be helpful in unravelling the mechanism of autoimmune arthritis.
###end p 12
###begin title 13
Materials and methods
###end title 13
###begin title 14
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 14
###begin p 15
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
DBA/1 mice were purchased from Charles River Laboratories, Japan. All mice were kept under specific pathogen-free conditions and all experiments were conducted in accordance with the University of Tsukuba ethical guidelines.
###end p 15
###begin title 16
GPI and synthetic peptides
###end title 16
###begin p 17
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 243 260 243 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 243 259 <span type="species:ncbi:562">Escherichia coli</span>
Recombinant mouse GPI and rhGPI were prepared as described previously [5,6]. Briefly, human GPI or mouse GPI cDNA was inserted into the plasmid pGEX-4T3 (Pharmacia, Uppsala, Sweden) for expression of glutathione S-transferase-tagged proteins. Escherichia coli harboring the pGEX-hGPI plasmid was allowed to proliferate at 37degreesC, before 0.1 mM isopropyl-beta-D-thiogalactopyranoside was added to the medium, followed by further culture overnight at 30degreesC. The bacteria were lysed with a sonicator and the supernatant was purified with a glutathione-sepharose column (Pharmacia, Uppsala, Sweden). The purity was estimated by SDS-PAGE.
###end p 17
###begin p 18
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Crude peptides were synthesised for epitope screening by Mimotopes (Melbourne, Victoria, Australia), and peptides with 90% purity were synthesised for a major epitope decision and induction of arthritis by Invitrogen (Carlsbad, CA). Candidate peptides, which were thought to bind the binding motif, were selected with web soft MHCPred (The Jenner Institute, Oxford, UK) [7].
###end p 18
###begin title 19
Induction of arthritis
###end title 19
###begin p 20
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
DBA/1 mice were immunised with 300 mug rhGPI for GPI-induced arthritis, or 10 mug or 25 mug synthetic peptide for peptide-induced arthritis in complete Freund's adjuvant (Difco Laboratories, Detroit, MI). The rhGPI and synthetic peptide were emulsified with complete Freund's adjuvant at a 1:1 ratio (v/v). For induction of arthritis, 150 mul of the emulsion was injected intradermally at the base of the tail of the mouse. On days 0 and 2 after immunisation, 200 ng of pertussis toxin was injected intraperitoneally to develop peptide-induced arthritis. The arthritis score was evaluated visually using a score of 0 to 3 for each paw. A score of 0 represented no evidence of inflammation, 1 represented subtle inflammation or localised oedema, 2 represented easily identified swelling but localised to either the dorsal or ventral surface of the paws, and 3 represented swelling in all areas of the paws.
###end p 20
###begin title 21
Treatments of arthritis with anti-IL-17 monoclonal antibodies
###end title 21
###begin p 22
###xml 21 25 <span type="species:ncbi:10090">mice</span>
To neutralise IL-17, mice were injected intraperitoneally with 100 mug of neutralising antibody or isotype control on day 7 or day 6, 8, and 10. Anti-IL-17 mAb MAB421 (IgG2a) was purchased from R&D Systems (Minneapolis, MN, USA). IgG2a isotype control was purchased from eBioscience (San Diego, CA, USA).
###end p 22
###begin title 23
Analysis of cytokine production
###end title 23
###begin p 24
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 124 126 124 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 345 347 343 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 638 640 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 754 756 744 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were sacrificed on the indicated day. Spleens were harvested and haemolysed with a solution of 0.83% NH4Cl, 0.12% NaHCO3 and 0.004% EDTA2Na in PBS. Single-cell suspensions were prepared in RPMI1640 medium (Sigma-Aldrich, St. Louis, MO) containing 10% FCS, 100 U/ml of penicillin, 100 mug/ml of streptomycin and 50 muM 2-mercaptoethanol. CD4+ T cells were isolated by MACS positive selection (Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the collected cells (>97%) was confirmed by flow cytometry. Splenic feeder cells treated with 50 mug/ml of mitomycin C were used as antigen presenting cells (APCs). The purified CD4+ T cells and APCs were co-cultured with 10 muM of the synthetic peptide at a ratio of 5:1 at 37degreesC under 5% CO2 for 24 hours. The supernatants were assayed for interferon (IFN)-gamma and IL-17 by Quantikine ELISA kit (R&D Systems, Minneapolis, MN).
###end p 24
###begin title 25
Intracellular cytokine staining and flow cytometric analysis
###end title 25
###begin p 26
###xml 144 145 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were sacrificed on day 5. The draining lymph nodes were harvested and single cell suspensions were prepared as described above. Cells (1x106/ml) were stimulated with 10 muM of the synthetic peptides in 96-well round bottom plates (Nunc, Roskilde, Denmark) for 24 hours and GoldiStop (BD PharMingen, San Diego, CA) was added for the last four hours of each culture. Cells were first stained extracellularly, fixed and permeabilised with Cytofix/Cytoperm solution (BD PharMingen, San Diego, CA) and then stained intracellularly. Samples were acquired on FACSCalibur (BD PharMingen, San Diego, CA) and data were analysed with FlowJo (Tree Star, Ashland, OR).
###end p 26
###begin title 27
Analysis of anti-GPI antibody
###end title 27
###begin p 28
###xml 960 961 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 281 286 <span type="species:ncbi:10090">mouse</span>
###xml 647 652 <span type="species:ncbi:10090">mouse</span>
Sera were taken from immunised mice on day 14 and diluted 1:500 in blocking solution (25% Block Ace (Dainippon Sumitomo Pharma, Osaka, Japan) in PBS) for antibody analysis. We also prepared 96-well plates (Sumitomo Bakelite, Tokyo, Japan) coated with 5 mug/ml rhGPI or recombinant mouse GPI for 12 hours at 4degreesC. After washing twice with a washing buffer (0.05% Tween20 in PBS), the blocking solution was used for blocking nonspecific binding for two hours at room temperature. After three washes, 150 mul of the diluted serum was added and incubated for two hoursat room temperature. After three washes, alkaline phosphatase-conjugated anti-mouse IgG was added at a final dilution of 1:5000, for one hour at room temperature. After three washes, colour was developed with substrate solution (1 alkaline phosphatase tablet (Sigma-Aldrich, St. Louis, MO, USA) per 5 ml alkaline phosphatase reaction solution (containing 9.6% diethanolamine and 0.25 mM MgCl2, pH 9.8)). Plates were incubated for 20 minutes at room temperature and optical density was measured by a microplate reader at 405 nm.
###end p 28
###begin title 29
Immunohistology
###end title 29
###begin p 30
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 566 572 <span type="species:ncbi:9913">bovine</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
For immunohistology, cryostat sections from ankle joints were prepared with the tape capture technique as described previously [8]. Briefly, ankle joints were taken from immunised mice on day 14 and placed in Tissue-Tek (Sakura Finetek, Torrance, CA) filled with 4% carboxymethyl cellulose compound (Finetec, Tokyo, Japan). Frozen ankles joints in the carboxymethyl cellulose compound were attached to the adhesive Cryofilm (Finetec, Tokyo, Japan) and were cut in the microtome. The sections on the adhesive film were fixed with cold acetone. After blocking with 2% bovine serum albumin and 0.05% Tween in PBS, the sections were stained with Alexa 546-conjugated anti-mouse IgG (Invitrogen, Carlsbad, CA) (200 ng/slide), and nuclei were counterstained with 4',6-diamidino-2-phenyindole dilactate (DAPI) (Sigma-Aldrich, St. Louis, MO, USA) (50 ng/slide). Fluorescence was detected with the Leica DMRA2 microscopy (Leica, Wetzlar, Germany). The images were acquired and processed with Leica FW4000 (Leica, Wetzlar, Germany).
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
All data were expressed as mean +/- standard error of the mean (SEM) or standard deviation (SD). Differences between groups and variables were examined for statistical significance using the Mann-Whitney's U test and the Spearman's rank correlation coefficient, respectively. A p < 0.05 denoted the presence of a statistically significant difference.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
I-Aq binding motif and epitope candidates
###end title 34
###begin p 35
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 355 357 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 392 399 392 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">90&#8211;105 </sub>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 425 432 425 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">89&#8211;101 </sub>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 471 479 471 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">181&#8211;209 </sub>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 492 500 492 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270 </sub>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 519 527 519 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270 </sub>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 380 386 <span type="species:ncbi:10090">murine</span>
###xml 441 448 <span type="species:ncbi:9031">chicken</span>
###xml 485 488 <span type="species:ncbi:10116">rat</span>
###xml 509 515 <span type="species:ncbi:9913">bovine</span>
###xml 535 540 <span type="species:ncbi:10090">mouse</span>
###xml 639 644 <span type="species:ncbi:9606">human</span>
To analyse T cell epitopes, we first investigated the binding motif of I-Aq from T cell epitopes reported in the literature because DBA/1 mice express only I-Aq as MHC class II. Based on the work by Bayrak and colleagues [9], the anchor motif of I-Aq would exist at P1, P4 and P7, therefore we predicted the binding motifs from amino acid sequences of I-Aq restricted epitopes on murine RNase90-105 [10], myelin basic protein89-101 [11,12], chicken type II collagen (CII)181-209 [13], rat CII256-270 [14,15], bovine CII256-270 [4] and mouse type II collagen [9] (Table 1). Next, we selected 32 types of peptides as core sequences from the human GPI 558 amino acid sequence, which is thought to bind the binding motif (Table 2), and synthesised 25 kinds of 20-mer peptides for screening, each containing the core sequence in its centre (Table 3).
###end p 35
###begin p 36
I-Aq binding motifs
###end p 36
###begin p 37
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 165 171 165 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">90&#8211;105</sub>
###xml 193 199 193 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">89&#8211;101</sub>
###xml 225 232 225 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">181&#8211;209</sub>
###xml 254 261 254 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270</sub>
###xml 286 294 286 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270 </sub>
###xml 153 159 <span type="species:ncbi:10090">murine</span>
###xml 201 208 <span type="species:ncbi:9031">chicken</span>
###xml 234 237 <span type="species:ncbi:10116">rat</span>
###xml 263 269 <span type="species:ncbi:9913">bovine</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
The anchor motif of I-Aq would exist at P1, P4 and P7, therefore we predicted the binding motif from amino acid sequences of I-Aq restricted epitopes on murine RNase90-105, myelin basic protein89-101, chicken type II collagen181-209, rat type II collagen256-270, bovine type II collagen256-270 and mouse type II collagen.
###end p 37
###begin p 38
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q</sup>
Core sequences of glucose-6-phosphate isomerase (GPI) amino acids binding I-Aq
###end p 38
###begin p 39
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
Thirty-two types of peptides were selected as core sequences from the GPI 558 amino acid sequence, which is thought to bind the binding motif. Amino acid residues that are thought to bind anchors of I-Aq are shown in bold letters.
###end p 39
###begin p 40
Synthetic peptides for screening T cell epitopes
###end p 40
###begin p 41
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
Listed are 25 20-mer unpurified peptides in which each core sequence were centred around. Amino acid residues constituting the core sequence and those thought to bind anchors of I-Aq are underlined and shown in bold letters, respectively.
###end p 41
###begin title 42
Epitope screening
###end title 42
###begin p 43
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 154 156 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 286 288 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 340 347 332 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327&#8211;346</sub>
###xml 376 383 368 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558</sub>
###xml 475 476 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 577 584 569 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink">282&#8211;294</sub>
###xml 629 632 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7 </sup>
###xml 633 635 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 708 716 700 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink">282&#8211;294 </sub>
###xml 822 829 814 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">280&#8211;299</sub>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
###xml 616 621 <span type="species:ncbi:10090">mouse</span>
rhGPI-specific CD4+ T cells differentiate into Th1 and Th17 [2], so we analysed IFN-gamma and IL-17 production for epitope screening when rhGPI-primed CD4+ T cells were stimulated with each synthetic peptide. The production of both IFN-gamma and IL-17 was pronounced when GPI-primed CD4+ T cells were stimulated with number 18 peptide (hGPI327-346) and number 25 peptide (hGPI539-558). Therefore, we considered that major epitopes exist in either of the two peptides (Figure 1). In the K/BxN mouse model of arthritis, KRN T cell receptor (TCR) transgenic T cells recognise mGPI282-294, the dominant epitope of K/BxN mouse, on I-Ag7 [16]. However, in the GPI-induced arthritis model, it was unlikely that hGPI282-294 was the dominant epitope because GPI-specific T cells did not react prominently to number 16 peptide (hGPI280-299).
###end p 43
###begin p 44
###xml 112 114 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Synthetic peptides number 18 and 25 produced marked simulation of glucose-6-phosphate isomerase (GPI) primed CD4<sup>+ </sup>T cells</bold>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 261 263 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 123 127 <span type="species:ncbi:10090">Mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
Synthetic peptides number 18 and 25 produced marked simulation of glucose-6-phosphate isomerase (GPI) primed CD4+ T cells. Mice were sacrificed on day 7 after immunisation. CD4+ T cells were purified from spleen cells of GPI-immunised DBA/1 mice. GPI-primed CD4+ T cells and antigen presenting cells (APCs) were co-cultured with 10 muM of synthetic peptide for 24 hours. The supernatants were assayed for interferon (IFN) gamma and interleukin (IL) 17 by ELISA. Data are averages +/- standard deviation of three culture wells. Representative data of three independent experiments.
###end p 44
###begin p 45
###xml 199 206 199 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327&#8211;346</sub>
###xml 235 242 235 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558</sub>
###xml 268 275 268 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327&#8211;346</sub>
###xml 310 318 310 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">328&#8211;336 </sub>
###xml 326 333 326 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">337&#8211;345</sub>
###xml 385 393 385 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 401 408 401 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">334&#8211;348</sub>
###xml 458 465 458 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558</sub>
###xml 506 513 506 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">533&#8211;552</sub>
###xml 545 547 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 618 626 618 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink">542&#8211;556 </sub>
###xml 634 641 634 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 803 810 799 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 856 858 852 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 910 911 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Because the synthetic peptides used for screening were not purified, we re-synthesised the 15-mer peptides with a purity of 90%; these peptides contained each core sequence of number 18 peptide (hGPI327-346) and number 25 peptide (hGPI539-558). Number 18 peptide (hGPI327-346) contains two core sequences (hGPI328-336 and hGPI337-345), so therefore we re-synthesised two peptides (hGPI325-339 and hGPI334-348). The former sequences of number 25 peptide (hGPI539-558) overlapped with number 24 peptide (hGPI533-552), which could not stimulate CD4+ T cells primed with GPI. Therefore we re-synthesised two peptides (hGPI542-556 and hGPI544-558) from the latter sequences of number 25 peptide (Table 4). We analysed IFN-gamma and IL-17 production for epitope screening as described above. The peptide (hGPI325-339) induced marked stimulation of GPI-primed CD4+ T cells, and was considered a major epitope (Figure 2).
###end p 45
###begin p 46
###xml 3 11 3 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GPI<sub>325&#8211;339 </sub>is a major epitope</bold>
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 300 307 299 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 313 320 312 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">334&#8211;348</sub>
###xml 326 334 325 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">542&#8211;556 </sub>
###xml 341 349 340 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 31 35 <span type="species:ncbi:10090">Mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
GPI325-339 is a major epitope. Mice were sacrificed on day 7 after immunisation. CD4+ T cells were purified from splenocytes of glucose-6-phosphate isomerase (GPI) immunised DBA/1 mice. GPI-primed CD4+ T cells and antigen presenting cells (APCs) were co-cultured with 10 muM of synthetic peptide hGPI325-339, hGPI334-348, hGPI542-556 or hGPI544-558 for 24 hours. The purity of each peptide was 90%. The supernatants were assayed for interferon (IFN) gamma and interleukin (IL) 17 by ELISA. Data are averages +/- standard deviation of five culture-wells. **p < 0.01 (Mann-Whitney's U test). Representative data of three independent experiments.
###end p 46
###begin p 47
Re-synthesised peptides used for determining a major epitope
###end p 47
###begin p 48
###xml 109 116 109 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327&#8211;346</sub>
###xml 144 151 144 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558</sub>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
The 15-mer peptides were synthesised with 90% purity, containing each core sequence of number 18 peptide (GPI327-346) and number 25 peptide (GPI539-558). Amino acid residues constituting the core sequence and those thought to bind the anchors of I-Aq are underlined and shown in bold letters, respectively.
###end p 48
###begin title 49
Immunisation with a major epitope induces arthritis similar to GPI-induced arthritis
###end title 49
###begin p 50
###xml 15 23 15 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 93 101 91 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 486 488 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 647 655 642 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 853 861 848 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558 </sub>
###xml 869 876 864 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 978 980 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1007 1015 1002 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 1203 1205 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">Mice</span>
To test if hGPI325-339 is arthritogenic, DBA/1 mice were immunised with 10 mug or 25 mug hGPI325-339 instead of GPI protein, and 200 ng of pertussis toxin was injected intraperitoneally on days 0 and 2 after immunisation. Arthritis resembling GPI-induced arthritis could be generated by immunisation with the peptide, including incidence, manifestations and severity. Symmetrical polyarthritis appeared on day 8, showed peak severity on day 14 and subsided gradually thereafter (Figure 3a). The use of different immunisation doses (10 and 25 mug) did not seem to affect the incidence and severity of arthritis. Immunised with 10 mug or 25 mug hGPI325-339 without injection of pertussis toxin could also induce arthritis. However, the arthritis was less severe than with pertussis toxin (data not shown). On the other hand, immunisation with neither hGPI539-558 nor hGPI544-558, which were considered minor epitopes in GPI-induced arthritis, could induce overt arthritis (Figure 3a). Mice immunised with hGPI325-339 developed severe swelling of the wrist and ankle joints. Histologically, severe synovitis was noted in the wrists in the forepaws, and at ankles and tarsal joints in the hind paws (Figure 3b and data not shown).
###end p 50
###begin p 51
###xml 22 30 22 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunisation with hGPI<sub>325&#8211;339 </sub>induces severe polyarthritis</bold>
###xml 105 112 104 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 118 126 117 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558 </sub>
###xml 133 140 132 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 164 172 162 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 181 188 179 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 551 559 546 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 728 736 723 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
Immunisation with hGPI325-339 induces severe polyarthritis. DBA/1 mice were immunised with 25 mug of hGPI325-339, hGPI539-558 or hGPI544-558, or 10 mug each of hGPI325-339 plus hGPI544-558, and 200 ng of pertussis toxin was injected intraperitoneally on days 0 and 2 after immunisation. (a) The mean arthritis score (+/- standard error of the mean (SEM)) of five mice in one representative experiment of two independent experiments. (b) Severe swelling of the wrist (upper panels) and ankle joints (middle panels) in mice immunised with 25 mug of hGPI325-339 compared with naive mice (arrowheads). Histological analysis of haematoxylin & eosin-stained sections of ankle joints taken from naive mice and mice on day 14 after hGPI325-339 immunization (lower panels) showed severe synovitis with massive infiltration of cells and hyperplasia of synovial tissue (arrowheads).
###end p 51
###begin title 52
Peptide-induced arthritis is mediated by Th17
###end title 52
###begin p 53
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 346 354 346 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
GPI-induced arthritis is Th17-mediated [2], so we explored the aetiological role of Th17 in peptide-induced arthritis. Like GPI-induced arthritis, one time administration of anti-IL-17 mAb on day 7 and three times administration on day 6, 8 and 10 significantly ameliorated the arthritis (Figure 4). From these data, the arthritis induced by hGPI325-339 was also considered to be Th17 mediated.
###end p 53
###begin p 54
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Anti-IL-17 monoclonal antibody (mAb) suppresses the development of arthritis</bold>
###xml 123 130 122 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
Anti-IL-17 monoclonal antibody (mAb) suppresses the development of arthritis. DBA/1 mice were immunised with 25 mug of hGPI325-339, and 200 ng of pertussis toxin was injected intraperitoneally on days 0 and 2 after immunisation. 100 mug of anti-IL-17 mAb or isotype control (control) was administered intraperitoneally on day 7 (upper panel) or day 6, 8, and 10 (lower panel) after immunisation (arrow). Mean arthritis score (+/- standard error of the mean (SEM)) of five mice per group. Representative data of two independent experiments. * p < 0.05, paragraph signp < 0.01 (Mann-Whitney's U test).
###end p 54
###begin title 55
###xml 25 33 25 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 79 86 79 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Immunisation of human GPI325-339 leads Th17 cells to cross-react with mouse GPI325-339
###end title 55
###begin p 56
###xml 57 65 57 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 110 117 110 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
We examined the pathogenesis of arthritis induced by hGPI325-339 by comparing it with mice immunised with hGPI544-558.
###end p 56
###begin p 57
###xml 127 135 127 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 191 199 191 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 227 235 227 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 295 303 295 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 381 389 381 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 396 403 396 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 440 447 440 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 453 460 453 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 466 474 466 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 481 489 481 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 511 518 511 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 583 591 583 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 627 635 627 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 675 683 675 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 750 757 750 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 825 832 825 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 911 920 911 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 1101 1110 1097 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
First, we speculated that the difference in cross-reactivity to mouse GPI might affect the incidence of arthritis, because hGPI325-339 (IWYINCFGCETHAML) has 13/15 amino acids homology to mGPI325-339 (IWYINCYGCETHALL) while hGPI544-558 (GLINFIKQQREARVQ) has only 9/15 amino acids homology to mGPI544-558 (GLISFIKQQRDTKLE). The draining lymph node cells from mice immunised with hGPI325-339 or hGPI544-558were cultured in the presence of hGPI325-339, mGPI325-339, hGPI544-558 or mGPI544-558 for 24 hours. The hGPI325-339-primed cells had distinct cross-reactive immune reaction to mGPI325-339 by producing IL-17, whereas the hGPI544-558 primed cells did not cross-react to mGPI544-558 (Figure 5a). As compared with the draining lymph node cells of hGPI325-339-immunised mice, IL-17 production was not remarkable in that of hGPI544-558-immunised mice even when the corresponding peptide was used as an antigen for in vitro stimulation (Figure 5a). The production of IFN-gamma was much lower than that of IL-17, and IL-4 production was not detectable independent of immunisation patterns and antigens for in vitro stimulation (data not shown).
###end p 57
###begin p 58
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cross-reactivity with peptides derived from mouse glucose-6-phosphate isomerase (GPI)</bold>
###xml 138 145 138 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 203 210 202 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 216 223 215 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 229 237 228 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 244 252 243 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 478 485 475 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 494 501 491 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 559 567 555 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 575 583 571 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 590 598 586 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 606 613 602 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 757 758 749 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 763 768 755 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
Cross-reactivity with peptides derived from mouse glucose-6-phosphate isomerase (GPI). (a) Draining lymph node (DLN) cells taken from hGPI325-339-immunised mice on day 5 were cultured with 10 muM of hGPI325-339, mGPI325-339, hGPI544-558 or mGPI544-558 for 24 hours. The supernatants were assayed for interleukin (IL) 17 by ELISA. Data are averages +/- standard deviation of three culture-wells. Representative data of three independent experiments. (b) DLN cells taken from hGPI325-339- or hGPI544-558-immunised mice on day 5 were cultured with 10 muM of hGPI325-339 and mGPI325-339 or hGPI544-558 and mGPI544-558, respectively. GoldiStop was added at the last four hours of each culture. Flow cytometry for IL-17 and interferon (IFN) gamma was gated in CD3+, CD4high cells. Representative flow cytometry data of three independent experiments with two mice per experiment.
###end p 58
###begin p 59
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 181 183 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 184 186 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 323 331 315 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 338 346 330 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 371 379 363 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 387 394 379 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 403 411 395 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 419 426 411 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 606 614 598 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 680 687 672 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 718 726 710 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 746 753 738 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 819 827 811 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 846 848 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
It has been reported that Th17 cells are not the only cellular sources of IL-17, but CD8+ T cells, natural killer T cells and gammadeltaT cells are also capable of producing IL-17 [17-22]. Therefore, we investigated the IL-17 producing cells using flow cytometry. The draining lymph node cells from mice immunised with hGPI325-339 or hGPI544-558 were stimulated with hGPI325-339 and mGPI325-339, or hGPI544-558 and mGPI544-558, respectively. Intracellular cytokine staining was performed without nonspecific stimulants, such as phorbol myristate acetate or ionomycin. We confirmed that immunisation of hGPI325-339 induced antigen-specific Th17 cells, which cross-reacted with mGPI325-339. However, immunisation of hGPI544-558 induced neither hGPI544-558-specific Th17 cells nor Th17 cells that can cross-react with mGPI544-558 remarkably (Figure 5b). These data indicate that induction of antigen-specific Th17 cells and cross-reactivity with mouse GPI might be the pathogenesis of peptide-induced arthritis.
###end p 59
###begin title 60
###xml 25 33 25 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Immunisation of human GPI325-339 leads B cells to produce anti-mouse GPI antibodies
###end title 60
###begin p 61
###xml 140 147 140 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 153 161 153 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 169 177 169 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 186 193 186 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 255 263 255 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 272 279 272 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 390 398 390 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 406 414 406 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 494 502 494 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 597 605 597 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 680 688 680 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 697 704 697 704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 790 798 790 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 894 902 894 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 911 918 911 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 974 982 974 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">Mice</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
###xml 340 345 <span type="species:ncbi:10090">mouse</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
To explore the importance of autoantibodies, we measured anti-human GPI antibodies and anti-mouse GPI antibodies in mice immunised with hGPI325-339, hGPI544-558 and hGPI325-339 plus hGPI544-558by ELISA. Mice immunised with rhGPI and the two peptides (hGPI325-339 plus hGPI544-558) produced high titres of anti-human GPI antibodies and anti-mouse GPI antibodies, and mice immunised with hGPI325-339 and hGPI544-558 hardly produced any anti-human GPI antibodies. However, mice immunised with hGPI325-339 produced significantly higher titres of anti-mouse GPI antibodies than mice immunised with hGPI544-558 (Figure 6a). It is noteworthy that immunisation with the two peptides (hGPI325-339 plus hGPI544-558) induced significantly higher titres of anti-mouse GPI antibodies than that with hGPI325-339 alone, whereas the severity and incidence of arthritis in mice immunised with two peptides (hGPI325-339 plus hGPI544-558) were comparable with those in mice immunised with hGPI325-339 alone (Figures 3a and 6a).
###end p 61
###begin p 62
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Titres of anti-mouse glucose-6-phosphate isomerase (GPI) antibodies were elevated in mice with arthritis</bold>
###xml 193 200 193 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 206 214 206 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 221 229 221 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 238 245 238 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 604 612 597 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 619 626 612 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
Titres of anti-mouse glucose-6-phosphate isomerase (GPI) antibodies were elevated in mice with arthritis. (a) Sera were taken on day 14 from mice immunised with recombinant human (rh) GPI, hGPI325-339, hGPI544-558 or hGPI325-339 plus hGPI544-558, and the titres of anti-human GPI antibodies and anti-mouse GPI antibodies were analysed by ELISA. Each symbol represents a single mouse. Data are mean optimal density +/- standard deviation. daggerp < 0.01 (Mann-Whitney's U test). Representative data of two independent experiments. (b) Ankle joints were taken on day 14 from mice immunised with rhGPI, hGPI325-339 or hGPI544-558. Cryostat sections of ankle joints were stained with anti-mouse IgG (red), and nuclei were counterstained with 4',6-diamidino-2-phenyindole dilactate (blue). Representative data of three independent experiments.
###end p 62
###begin p 63
###xml 203 211 203 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 219 227 219 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 236 243 236 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
We further investigated the difference of the correlation between anti-mouse GPI antibodies and arthritis score among immunisation patterns. Each of the three different immunisation patterns (rhGPI, hGPI325-339 and hGPI325-339 plus hGPI544-558) showed no positive correlation between anti-mouse GPI antibodies and arthritis score (Table 5).
###end p 63
###begin p 64
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Correlation between anti-mouse glucose-6-phosphate isomerase (GPI) antibodies titres and arthritis score
###end p 64
###begin p 65
###xml 83 91 83 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 98 106 98 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 115 122 115 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 397 402 <span type="species:ncbi:10090">mouse</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Sera were taken on day 14 from mice immunised with recombinant human (rh) GPI, hGPI325-339 or hGPI325-339 plus hGPI544-558. The correlation between the titres of anti-GPI antibodies and arthritis score on day 14 were statistically analysed with the Spearman's rank correlation coefficient. In the case of five samples, Rho values above 0.900 indicate significant positive correlation between anti-mouse GPI antibody titres and arthritis score, whereas Rho values below -0.900 indicate significant negative correlation (p < 0.05). Five mice per group. Representative data of two independent experiments.
###end p 65
###begin p 66
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 257 265 257 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 370 378 370 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
Next, we investigated the existence of IgG on the cartilage surface by immunohistology, because GPI were proved to deposit on the cartilage surface of normal naive mice [23]. The cryostat sections of ankle joints from naive mice and mice immunised with hGPI544-558 did not show IgG deposit on the cartilage surface. However, those from mice immunised with rhGPI and hGPI325-339 showed IgG deposits (Figure 6b). These data indicate that anti-mouse GPI antibodies may play a role in the development of peptide-induced arthritis.
###end p 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 319 320 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 336 338 332 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 556 557 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 558 559 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 601 603 597 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
GPI, a ubiquitous glycolytic enzyme, is a new autoantigen candidate in autoimmune arthritis [5,6]. GPI-induced arthritis is induced by immunisation of genetically unaltered DBA/1 mice with rhGPI [1]. We report here the therapeutic efficacies of mAb to tumour necrosis factor-alpha and IL-6 and CTLA-4 Ig in this model [3]. Moreover, CD4+ T cells, especially Th17 cells, seem to be more important than B cells, because administration of anti-CD4 mAb or anti-IL-17 mAb markedly ameliorate the progress of arthritis independent of anti-GPI antibodies titres [1,2]. Therefore, exploring the epitope of CD4+ T cells and its arthritogenic effect is important for understanding the pathological mechanisms.
###end p 68
###begin p 69
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q</sup>
###xml 168 176 168 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 243 250 243 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 322 330 322 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">256&#8211;270 </sub>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 512 513 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q</sup>
###xml 730 737 730 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">124&#8211;402</sub>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1130 1131 1130 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 312 318 <span type="species:ncbi:9913">bovine</span>
###xml 709 715 <span type="species:ncbi:9913">bovine</span>
###xml 867 873 <span type="species:ncbi:9913">bovine</span>
###xml 1000 1006 <span type="species:ncbi:9913">bovine</span>
###xml 1094 1100 <span type="species:ncbi:9913">bovine</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
In this study, we investigated the binding motif of I-Aq from T cell epitopes considered to bind to I-Aq, synthesised peptides of epitope candidates and identified hGPI325-339 as a major epitope. Interestingly, the MHC binding residues of hGPI325-339(IWYINCFGCETHAML) at P1, P4 and P7 were the same as those for bovine CII256-270 (GEPGIAGFKGEQGPK), the dominant epitope of collagen-induced arthritis [4]. These findings indicate that the binding motif (P1 I, P4 F, P7 E) might have high binding affinity with I-Aq, and the peptides with this motif-MHC complexes might be effectively recognised by TCRs and could be arthritogenic in some condition. Although immunisation with a fragment of cyanogen bromide of bovine CII, CB11 (CII124-402), which contains the dominant epitope, can induce arthritis, the severity and incidence are much lower than arthritis induced by bovine CII protein [4]. Other fragments (CB8, CB9, CB10 and CB12) do not induce arthritis, as is explained by the production of anti-bovine CII antibodies. Immunisation with CB11 fragment produces five times more antibodies to bovine CII than any other fragment [4]. The observation that administration of anti-CD4 mAb after the onset of arthritis did not ameliorate the arthritis [24,25] and a combination of mAb to CII can passively transfer arthritis to naive mice [26] also emphasises the importance of autoantibodies to the induction of collagen-induced arthritis.
###end p 69
###begin p 70
###xml 50 58 50 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 126 134 126 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 220 228 220 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 254 261 254 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 896 904 896 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 912 920 912 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558 </sub>
###xml 1150 1176 1150 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterim tuberculosis </italic>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
Our study demonstrated that immunisation with hGPI325-339 induced antigen-specific Th17 cells, which can cross-react with mGPI325-339 and lead B cells to produce anti-mouse GPI antibodies. However, immunisation with hGPI544-558 could not even induce hGPI544-558-specific Th17 cells. The difference of ability of Th17 induction between two peptides may come from MHC-binding affinity and TCR-binding affinity. A peptide that is likely to bind to MHC class II with high affinity and interacts strongly with the T cell receptor tends to stimulate Th1-cell response, whereas a peptide with low binding affinity to MHC class II and T cell receptor tends to elicit Th2-cell response [27,28]. Although the relationship between Th17 differentiation and the strength of TCR signalling and MHC-binding affinity has not been clarified, it is possible that the difference in amino acid sequences between hGPI325-339 and hGPI544-558 might affect the I-Aq binding affinity and the TCR signalling, and consequently lead to the difference in extent of antigen-specific Th17 cells. In this study, we did not detect any IL-4 production, which is an adjuvant effect of Mycobacterim tuberculosis and pertussis toxin.
###end p 70
###begin p 71
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g7 </sup>
###xml 62 69 62 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">282&#8211;294</sub>
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 661 662 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 721 728 713 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339</sub>
###xml 989 991 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 825 830 <span type="species:ncbi:10090">mouse</span>
###xml 946 951 <span type="species:ncbi:10090">mouse</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
###xml 1096 1101 <span type="species:ncbi:10090">mouse</span>
###xml 1190 1195 <span type="species:ncbi:10090">mouse</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
In K/BxN mice expressing I-Ag7 as MHC class II molecules, mGPI282-294-specific CD4+ T cells lead B cells to produce anti-mouse GPI antibodies [16]. The anti-mouse GPI antibodies from K/BxN mice have such high affinity that IgG transfer of K/BxN mice can provoke arthritis in normal mice [6]. In comparison, the anti-mouse GPI antibodies from GPI-induced arthritis alone are not sufficient for the development of arthritis because IgG transfer from mice immunised with rhGPI can not provoke arthritis. However, IgG signalling through FcgammaR seems necessary for the induction of GPI-induced arthritis because FcgammaR-deficient mice are resistant to arthritis [1]. Moreover, the data that transfer of rhGPI-primed or hGPI325-339-primed Th17 cells to naive DBA/1 mice can not induce arthritis emphasises the necessity of anti-mouse GPI antibodies (unpublished observation). Considering the data that there are no positive correlation between anti-mouse GPI antibodies and arthritis score [[29] and unpublished observation], and arthritis-resistant mice like C57BL/6 produce as high titres of anti-mouse GPI antibodies as DBA/1 when immunised with rhGPI (1 and unpublished observation), anti-mouse GPI antibodies may play a subordinate role in the development of GPI-induced arthritis and peptide-induced arthritis in DBA/1 mice.
###end p 71
###begin p 72
###xml 57 65 57 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558 </sub>
###xml 105 113 105 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327&#8211;346 </sub>
###xml 151 159 151 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">542&#8211;556 </sub>
###xml 167 174 167 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">544&#8211;558</sub>
###xml 243 251 243 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558 </sub>
###xml 293 300 293 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558</sub>
###xml 371 379 371 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 389 397 389 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">539&#8211;558 </sub>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
In the process of epitope screening, the response to hGPI539-558 peptide was comparable with that to hGPI327-346 peptide; however, the response to hGPI542-556 and hGPI544-558, which were synthesised with 90% purity, was lower than that to hGPI539-558 peptide. Furthermore, the response to hGPI539-558, which was re-synthesised with 90% purity, was much lower than to hGPI325-339 or to hGPI539-558 peptide for screening (data not shown). These results could be explained by differences in the purity of the synthetic peptides. The synthetic peptides used for screening (peptides numbers 1 to 25, Table 2) were unpurified, and the purity of each peptide would have been quite different, although the exact purity was unchecked by the product maker. Therefore, it is possible that the purity of number 25 peptide might have been much higher than that of number 18 peptide, or alternatively, number 25 peptide may have contained other peptides through peptide synthesis.
###end p 72
###begin p 73
###xml 182 184 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 399 407 399 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 470 478 470 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 590 598 590 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 872 880 872 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 934 942 934 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink">325&#8211;339 </sub>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 300 305 <span type="species:ncbi:9606">human</span>
From a probability point of view, it is possible that other epitopes exist in some regions of human GPI-amino acid sequence from which we did not synthesise the peptides, because I-Aq may have another binding motif and our synthesised peptides covered only the 399/558 (71.5%) amino acid residues of human GPI protein, not the whole length. However, two experimental pieces of data support that hGPI325-339 may be the dominant epitope. One is that immunisation with hGPI325-339 provoked arthritis similar to that induced by rhGPI protein. The other is that intraperitoneal injection of hGPI325-339 after the onset of arthritis significantly ameliorated the progress of arthritis (data not shown). Because systemic administration of a dominant epitope leads to anergy of pathogenic T cells or results in activation-induced cell death [30,31], this inhibitory effect of hGPI325-339 on GPI-induced arthritis supports the notion that hGPI325-339 may be the dominant epitope.
###end p 73
###begin p 74
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 342 344 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
Cross-reactivity is considered the one of mechanisms of autoimmune diseases. We previously identified patients with RA who have GPI-reactive CD4+ T cells and found that some of them express human leucocyte antigen-DR4 as MHC class II [32]. Because the I-Aq binding motif resembles DR4 [9], further studies are needed to define epitopes of CD4+ T cells in such patients and search proteins that have homology to the epitopes.
###end p 74
###begin title 75
Conclusions
###end title 75
###begin p 76
###xml 134 138 <span type="species:ncbi:10090">mice</span>
This study is the first report of experimental arthritis induced by immunisation with a single short peptide in genetically unaltered mice. The fact that an immunological reaction to a single short peptide of ubiquitously expressed protein causes polyarthritis provides new insight to the understanding of autoimmune arthritis.
###end p 76
###begin title 77
Abbreviations
###end title 77
###begin p 78
###xml 246 250 <span type="species:ncbi:9913">calf</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
APC: antigen-presenting cell; CIA: collagen-induced arthritis; CII: type II collagen; CTLA-4 Ig: cytotoxic T-lymphocyte antigen 4 immunoglobulin; DAPI: 4',6-diamidino-2-phenyindole, dilactate; ELISA: enzyme-linked immunosorbent assay; FCS: fetal calf serum; GPI: glucose-6-phosphate isomerase; IFN: interferon; IL: interleukin; mAb: monoclonal antibody; MHC: major histocompatibility complex; PBS: phosphate-buffered saline; RA: rheumatoid arthritis; rh: recombinant human; SD: standard deviation; SEM: standard error of the mean; TCR: T cell receptor; Th: T helper.
###end p 78
###begin title 79
Competing interests
###end title 79
###begin p 80
The authors declare that they have no competing interests.
###end p 80
###begin title 81
Authors' contributions
###end title 81
###begin p 82
KI wrote the manuscript and conceived of the study. YT and AI assisted experiments and statistical analysis. IM and TS participated in its full design and coordination, and DG, SI and AK participated in discussions.
###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
This work was supported in part by a grant from The Japanese Ministry of Science and Culture (IM, TS).
###end p 84
###begin article-title 85
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in generally unaltered mice
###end article-title 85
###begin article-title 86
Crucial role of IL-6/IL-17 axis in the induction of arthritis by glucose-6-phosphate isomerase
###end article-title 86
###begin article-title 87
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis
###end article-title 87
###begin article-title 88
###xml 117 119 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 88 94 <span type="species:ncbi:9913">bovine</span>
###xml 114 118 <span type="species:ncbi:10090">H-2q</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha1(II)-CB11 in H-2q mice
###end article-title 88
###begin article-title 89
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders
###end article-title 89
###begin article-title 90
Arthritis provoked by linked T and B recognition of a glycolytic enzyme
###end article-title 90
###begin article-title 91
MHCPred
###end article-title 91
###begin article-title 92
Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants
###end article-title 92
###begin article-title 93
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
T cell response of I-Aq mice to self type II collagen: meshing of the binding motif of the I-Aq molecule with repetitive sequences results in autoreactivity to multiple epitopes
###end article-title 93
###begin article-title 94
###xml 68 74 <span type="species:ncbi:9913">bovine</span>
Identification and characterization of a T cell-inducing epitope of bovine ribonuclease that can be restricted by multiple class II molecules
###end article-title 94
###begin article-title 95
###xml 55 61 <span type="species:ncbi:10090">murine</span>
Major histocompatibility complex-linked control of the murine immune response to myelin basic protein
###end article-title 95
###begin article-title 96
###xml 24 30 <span type="species:ncbi:10090">murine</span>
Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein
###end article-title 96
###begin article-title 97
###xml 99 104 <span type="species:ncbi:9031">chick</span>
Identification and characterization of a tolerogenic T cell determinant within residues 181-209 of chick type II collagen
###end article-title 97
###begin article-title 98
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">q </sup>
###xml 86 90 <span type="species:ncbi:10090">H-2q</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection
###end article-title 98
###begin article-title 99
###xml 50 56 <span type="species:ncbi:10090">murine</span>
T cell epitopes of type II collagen that regulate murine collagen-induced arthritis
###end article-title 99
###begin article-title 100
Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR
###end article-title 100
###begin article-title 101
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells
###end article-title 101
###begin article-title 102
Transforming growth factor-beta induces development of the T (H) 17 lineage
###end article-title 102
###begin article-title 103
CD8+ IL-17 producing T cells are important effector functions for the elicitation of contact hypersensitivities responses
###end article-title 103
###begin article-title 104
Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia
###end article-title 104
###begin article-title 105
Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis
###end article-title 105
###begin article-title 106
###xml 83 109 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection
###end article-title 106
###begin article-title 107
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease
###end article-title 107
###begin article-title 108
Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4
###end article-title 108
###begin article-title 109
###xml 40 46 <span type="species:ncbi:10090">murine</span>
Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunization
###end article-title 109
###begin article-title 110
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 58 65 <span type="species:ncbi:562">E. coli</span>
Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen
###end article-title 110
###begin article-title 111
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells
###end article-title 111
###begin article-title 112
CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR
###end article-title 112
###begin article-title 113
Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase
###end article-title 113
###begin article-title 114
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
###end article-title 114
###begin article-title 115
Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
###end article-title 115
###begin article-title 116
Characterisation of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
###end article-title 116

